These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23060290)

  • 1. The challenges of evaluating dose response in flexible-dose trials using marginal structural models.
    Lipkovich I; Mallinckrodt CH; Faries DE
    Pharm Stat; 2012; 11(6):485-93. PubMed ID: 23060290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating dose response from flexible dose clinical trials.
    Lipkovich I; Adams DH; Mallinckrodt C; Faries D; Baron D; Houston JP
    BMC Psychiatry; 2008 Jan; 8():3. PubMed ID: 18179713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of dose-response in flexible dose titration clinical studies.
    Xu XS; Yuan M; Nandy P
    Pharm Stat; 2012; 11(4):280-6. PubMed ID: 22407972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mis-specification of the treatment model on estimates from a marginal structural model.
    Lefebvre G; Delaney JA; Platt RW
    Stat Med; 2008 Aug; 27(18):3629-42. PubMed ID: 18254127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marginal mean weighting through stratification: a generalized method for evaluating multivalued and multiple treatments with nonexperimental data.
    Hong G
    Psychol Methods; 2012 Mar; 17(1):44-60. PubMed ID: 21843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice.
    Severus E; Lipkovich I; Seemüller F; Obermeier M; Grunze H; Bernhard B; Dittmann S; Riedel M; Möller HJ
    World J Biol Psychiatry; 2013 Jul; 14(5):386-95. PubMed ID: 22098147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based approaches for time-dependent dose finding with repeated binary data.
    Benda N
    Stat Med; 2010 May; 29(10):1096-106. PubMed ID: 20082362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating treatment effects from a randomized clinical trial in the presence of a secondary treatment.
    Zhang M; Wang Y
    Biostatistics; 2012 Sep; 13(4):625-36. PubMed ID: 22510495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighted Kaplan-Meier estimators for two-stage treatment regimes.
    Miyahara S; Wahed AS
    Stat Med; 2010 Nov; 29(25):2581-91. PubMed ID: 20799259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of longitudinal marginal structural models.
    Bryan J; Yu Z; Van Der Laan MJ
    Biostatistics; 2004 Jul; 5(3):361-80. PubMed ID: 15208200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity analysis for the estimation of rates of change with non-ignorable drop-out: an application to a randomized clinical trial of the vitamin D3.
    Matsuyama Y
    Stat Med; 2003 Mar; 22(5):811-27. PubMed ID: 12587107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitting marginal structural models: estimating covariate-treatment associations in the reweighted data set can guide model fitting.
    Pullenayegum EM; Lam C; Manlhiot C; Feldman BM
    J Clin Epidemiol; 2008 Sep; 61(9):875-81. PubMed ID: 18486447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.
    Hernán MA; Brumback BA; Robins JM
    Stat Med; 2002 Jun; 21(12):1689-709. PubMed ID: 12111906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dose-finding designs for narrow-therapeutic-index drugs: concentration-controlled vs. dose-controlled trials.
    Lledó-García R; Hennig S; Karlsson MO
    Clin Pharmacol Ther; 2009 Jul; 86(1):62-9. PubMed ID: 19339964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An application of model-fitting procedures for marginal structural models.
    Mortimer KM; Neugebauer R; van der Laan M; Tager IB
    Am J Epidemiol; 2005 Aug; 162(4):382-8. PubMed ID: 16014771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive truncated weighting for improving marginal structural model estimation of treatment effects informally censored by subsequent therapy.
    Bai X; Liu J; Li L; Faries D
    Pharm Stat; 2015; 14(6):448-54. PubMed ID: 26436533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dynamic treatment regimes via inverse probability weighting.
    Hernán MA; Lanoy E; Costagliola D; Robins JM
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):237-42. PubMed ID: 16611197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doubly robust and multiple-imputation-based generalized estimating equations.
    Birhanu T; Molenberghs G; Sotto C; Kenward MG
    J Biopharm Stat; 2011 Mar; 21(2):202-25. PubMed ID: 21390997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.